American Journal of Medical Sciences and Medicine
ISSN (Print): 2327-6681 ISSN (Online): 2327-6657 Website: Editor-in-chief: Apply for this position
Open Access
Journal Browser
American Journal of Medical Sciences and Medicine. 2015, 3(5), 67-69
DOI: 10.12691/ajmsm-3-5-2
Open AccessCase Report

Systemic Steroid for Exudative Retinal Detachment Following Laser Photocoagulation for Retinopathy of Prematurity

Emrah Utku Kabatas MD1, , Pinar Altiaylik Ozer MD FEBO1, Bengi Ece Kurtul MD1, Naciye Kabatas MD2, Serdar Beken MD1, Aysegul Zenciroglu MD1 and Nurullah Okumus MD1

1Department of Ophthalmology, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey

2Department of Ophthalmology, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey

Pub. Date: November 16, 2015

Cite this paper:
Emrah Utku Kabatas MD, Pinar Altiaylik Ozer MD FEBO, Bengi Ece Kurtul MD, Naciye Kabatas MD, Serdar Beken MD, Aysegul Zenciroglu MD and Nurullah Okumus MD. Systemic Steroid for Exudative Retinal Detachment Following Laser Photocoagulation for Retinopathy of Prematurity. American Journal of Medical Sciences and Medicine. 2015; 3(5):67-69. doi: 10.12691/ajmsm-3-5-2


Retinopathy of prematurity (ROP) is one of the causes of blindness in childhood. The treatment modalities of this disease are laser photocoagulation (LP) and/or intravitreal anti-VEGF agents. But there are many side effects of the laser treatment such as lens opacity, iris and cornea burns, retinal and choroidal hemorrhages. Exudative retinal detachment (ERD) has been reported as a rare complication of LP for the treatment of ROP. But there is no consensus about how to treat of this condition. Here we present a case of ERD after LP for ROP although appropriate laser settings and successfully treated by systemic steroid administration.

exudative retinal detachment laser photocoagulation retinopathy of prematurity steroid

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2006; 117:572-576.
[2]  Azad RV, Pasumala L, Kumar H, et al. Prospective randomized evaluation of diode-laser and cryotherapy in prethreshold retinopathy of prematurity. Clin Experiment Ophthalmol. 2004; 32: 251-254.
[3]  Chen J, Stahl A, Hellstrom A, Smith LE.Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr. 2011;23(2):173-178.
[4]  Irvine WD, Smiddy WE, Nicholson DH. Corneal and iris burns with laser indirect ophthalmoscope. Am J Ophthalmol. 1990; 110:311-314.
[5]  Preslan MW. Laser therapy for retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 1993;30:80-83.
[6]  Moshfeghi DM, Silva RA, Berrocal AM.Exudative Retinal Detachment following Photocoagulation in Older Premature Infants For Retinopathy of Prematurity: Description and Management. Retina. 2014;34(1):83-86.
[7]  Noonan CP, Clark DI Acute serous detachment with argon laser photocoagulation in retinopathy of prematurity JAAPOS. 1997;1(3):183-184
[8]  Berman DH, Deutsch JA. Bilateral spontaneous pigment epithelial detachments in a premature neonate. Arch Ophthalmol. 1994; 112161-112164
[9]  Ehmann D, Greve M. Intravitreal bevacizumab for exudative retinal detachment post laser therapy for retinopathy of prematurity. Can J Ophthalmol. 2014;49(2):228-31.
[10]  Armada- Maresca F, Peralta-Calvo J, Pastora-Salvador N, Grabowska A, Vallejo-Garcia External subretinal drainage, bevacizumab, and scleral buckling for complete exudative retinal detachment after photocoagulation in retinopathy of prematurity. J.Retin Cases Brief Rep. 2014;8(1):33-6.
[11]  Lalwani GA, Berrocal AM, Murray TG, et al. Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity. Retina. 2008;28(3Suppl.):S13-S18.
[12]  Newman H, Finger PT, Chin KJ, Pavlick AC Systemic bevacizumab (Avastin) for exudative retinal detachment secondary to choroidal melanoma. Eur J Ophthalmol. 2011; 21(6): 796-801.
[13]  Marmor MF, Yao XY. Conditions necessary for the formation of serous detachment. Experimental evidence from the cat. ArchOphthalmol 1994;112:830-838.
[14]  Muni RH, KohlyRP, Charonis AC,Lee TC.Retinoschis is detected with handheld spectral-domain optical coherence tomography in neonates with advanced retinopathy of prematurity. Arch Ophthalmol. 2010; 128: 57-62.